With only one medication historically used to treat diabetic kidney disease, study of combination therapies with newer ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

EXCLUSIVE: The dialysis company believes the impact of the treatments on its own performance will be ‘neutral to positive’ ...

While the renal benefits of oral semaglutide vs placebo in the SOUL trial didn't match the effects seen with the injectable ...

Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge ...

An international clinical trial, led in the UK by Swansea’s Joint Clinical Research Facility (JCRF), has found that ...

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the ...

DelveInsight's Chronic Kidney Disease pipeline report depicts a robust space with 75+ active players working to develop 80+ ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease ... Richard Pratley, MD is a paid Novo Nordisk, Inc. spokesperson.

‘Address unmet needs in serious chronic diseases’ Martin Holst Lange, Executive Vice President, Development, Novo Nordisk ... liver, and kidney disease. Same thing for amacretin,” Lange ...